The combination of MELD score and ICG liver testing predicts length of stay in the ICU and hospital mortality in liver transplant recipients

BMC Anesthesiology

Volumn 14, Issue 1, 2014, Pages

  Klinzing, Stephanie ^a   Brandi, Giovanna ^a   Stehberger, Paul A ^a   Raptis, Dimitri A ^a   Béchir, Markus ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Hospital mortality; Indocyanine green liver testing; Length of stay in the ICU; MELD score

Indexed keywords

BILIRUBIN; BLOOD CLOTTING FACTOR 5;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; INDOCYANINE PLASMA DISAPPEARANCE RATE; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE PERIOD; RECEIVER OPERATING CHARACTERISTIC;

EID: 84928312855     PISSN: None     EISSN: 14712253     Source Type: Journal    
DOI: 10.1186/1471-2253-14-103     Document Type: Article

References (41)

1. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR: A model to predict survival in patients with end-stage liver disease. Hepatology 2001,33(2):464-470. 10.1053/jhep.2001.22172
2. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, United Network for Organ Sharing Liver Disease Severity Score Committee: Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003,124(1):91-96. 10.1053/gast.2003.50016
3. Ravaioli M, Grazi GL, Ballardini G, Cavrini G, Ercolani G, Cescon M, Zanello M, Cucchetti A, Tuci F, Del Gaudio M, Varotti G, Vetrone G, Trevisani F, Bolondi L, Pinna AD: Liver transplantation with the Meld system: a prospective study from a single European center. Am J Transplant 2006,6(7):1572-1577. 10.1111/j.1600-6143.2006.01354.x
4. Oberkofler CE, Dutkowski P, Stocker R, Schuepbach RA, Stover JF, Clavien PA, Bechir M: Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients. Crit Care 2010,14(3):R117. 10.1186/cc9068
5. Brown RS Jr, Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P, Lobritto S, Emond JC: Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002,8(3):278-284. 10.1053/jlts.2002.31340
6. Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, Velidedeoglu E, Chapman WC, Markmann JF: Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004,77(1):99-106. 10.1097/01.TP.0000101009.91516.FC
7. Jacob M, Copley LP, Lewsey JD, Gimson A, Toogood GJ, Rela M, van der Meulen JH, UK and Ireland Liver Transplant Audit: Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004,10(7):903-907. 10.1002/lt.20169
8. Chung IS, Park M, Ko JS, Gwak MS, Kim GS, Lee SK: Which score system can best predict recipient outcomes after living donor liver transplantation? Transplant Proc 2012,44(2):393-395. 10.1016/j.transproceed.2012.01.064
9. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, Merion RM: Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006,6(4):783-790. 10.1111/j.1600-6143.2006.01242.x
10. Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, Guarrera JV, Brown RS Jr, Emond JC: Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008,8(12):2537-2546. 10.1111/j.1600-6143.2008.02400.x
11. Organ Procurement and Transplantation Network 2011. http://www.srtr.org/
12. Santoyo J, Suarez MA, Fernandez-Aguilar JL, Perez Daga JA, Sanchez-Perez B, Ramirez C, Aranda JM, Rodriguez-Canete A, Gonzalez-Sanchez A: True impact of the indication of cirrhosis and the MELD on the results of liver transplantation. Transplant Proc 2006,38(8):2462-2464. 10.1016/j.transproceed.2006.08.015
13. Jung B, Cisse M, Chanques G, Arsac E, Bismuth M, Panaro F, Perrigault PF, Souche B, Gallix B, Verzilli D, Delay JM, Navarro F, Pageaux GP, Jaber S: Causes of early mortality after liver transplantation: a twenty-years single centre experience. Ann Fr Anesth Reanim 2011,30(12):899-904. 10.1016/j.annfar.2011.06.014
14. Medeiros DM, Oliveira AC, Barros MF, Cury RA, Sette H Jr, Abdala E, Canedo LF, Makdissi FF, Andraus W, Martino RB, Rocha-Santos V, Figueira ER, Machado MA, Carrilho FJ, Cançado EL, Bacchella T, Machado MC: Early mortality in liver transplantation: bilirubin as predictor of outcome. Transplant Proc 2004,36(4):931-932. 10.1016/j.transproceed.2004.03.112
15. Karvellas CJ, McPhail M, Pink F, Asthana S, Muiesan P, Heaton N, Auzinger G, Bernal W, Eltringham I, Wendon JA: Bloodstream infection after elective liver transplantation is associated with increased mortality in patients with cirrhosis. J Crit Care 2011,26(5):468-474. 10.1016/j.jcrc.2010.12.018
16. Levesque E, Hoti E, Azoulay D, Honore I, Guignard B, Vibert E, Ichai P, Antoun F, Saliba F, Samuel D: Pulmonary complications after elective liver transplantation-incidence, risk factors, and outcome. Transplantation 2012,94(5):532-538. 10.1097/TP.0b013e31825c1d41
17. Razonable RR, Findlay JY, O'Riordan A, Burroughs SG, Ghobrial RM, Agarwal B, Davenport A, Gropper M: Critical care issues in patients after liver transplantation. Liver Transpl 2011,17(5):511-527. 10.1002/lt.22291
18. Saner FH, Sotiropoulos GC, Radtke A, Fouzas I, Molmenti EP, Nadalin S, Paul A: Intensive care unit management of liver transplant patients: a formidable challenge for the intensivist. Transplant Proc 2008,40(9):3206-3208. 10.1016/j.transproceed.2008.08.069
19. Ferraz-Neto BH, Zurstrassen MP, Hidalgo R, Meira-Filho SP, Rezende MB, Paes AT, Afonso RC: Analysis of liver transplantation outcome in patients with MELD Score > or =30. Transplant Proc 2008,40(3):797-799. 10.1016/j.transproceed.2008.03.016
20. Shaked A, Nunes FA, Olthoff KM, Lucey MR: Assessment of liver function: pre- and peritransplant evaluation. Clin Chem 1997,43(8 Pt 2):1539-1545.
21. Sakka SG, Reinhart K, Meier-Hellmann A: Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 2002,122(5):1715-1720. 10.1378/chest.122.5.1715
22. Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S: Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 2001,29(6):1159-1163. 10.1097/00003246-200106000-00014
23. Levesque E, Saliba F, Benhamida S, Ichai P, Azoulay D, Adam R, Castaing D, Samuel D: Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation. Liver Transpl 2009,15(10):1358-1364. 10.1002/lt.21805
24. Olmedilla L, Perez-Pena JM, Ripoll C, Garutti I, de Diego R, Salcedo M, Jimenez C, Banares R: Early noninvasive measurement of the indocyanine green plasma disappearance rate accurately predicts early graft dysfunction and mortality after deceased donor liver transplantation. Liver Transpl 2009,15(10):1247-1253. 10.1002/lt.21841
25. Hori T, Iida T, Yagi S, Taniguchi K, Yamamoto C, Mizuno S, Yamagiwa K, Isaji S, Uemoto S: K(ICG) value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transpl 2006,12(4):605-613. 10.1002/lt.20713
26. Diaz S, Perez-Pena J, Sanz J, Olmedilla L, Garutti I, Barrio JM: Haemodynamic monitoring and liver function evaluation by pulsion cold system Z-201 (PCS) during orthotopic liver transplantation. Clin Transplant 2003,17(1):47-55. 10.1034/j.1399-0012.2003.02072.x
27. Faybik P, Krenn CG, Baker A, Lahner D, Berlakovich G, Steltzer H, Hetz H: Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl 2004,10(8):1060-1064. 10.1002/lt.20205
28. McCormack L, Selzner M, Clavien P-A: The Transplant Operation. In Medical Care of Liver Transplantation. Edited by: Killenberg P, Clavien PA. Oxford, England: Blackwell Publishing; 2006.
29. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Scholmerich J: Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Int Ascites Club Hepatol 1996,23(1):164-176.
30. Salerno F, Gerbes A, Gines P, Wong F, Arroyo V: Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007,56(9):1310-1318.
31. Merion RM, Goodrich NP, Feng S: How can we define expanded criteria for liver donors? J Hepatol 2006,45(4):484-488. 10.1016/j.jhep.2006.07.016
32. Kirshwood BR, Sterne JAC: Essential Medical Statistics. 2nd edition. Malden (Massachusetts, USA): Blackwell Science LTD; 2003.
33. Youden WJ: Index for rating diagnostic tests. Cancer 1950,3(1):32-35. Publisher Full Text 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
34. Kraemer HC: Reconsidering the odds ratio as a measure of 2x2 association in a population. Stat Med 2004,23(2):257-270. 10.1002/sim.1714
35. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM: The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003,56(11):1129-1135. 10.1016/S0895-4356(03)00177-X
36. Obuchowski NA: Receiver operating characteristic curves and their use in radiology. Radiology 2003,229(1):3-8. 10.1148/radiol.2291010898
37. Schneider L, Spiegel M, Latanowicz S, Weigand MA, Schmidt J, Werner J, Stremmel W, Eisenbach C: Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation. Hepatobiliary Pancreat Dis Int 2011,10(4):362-368. 10.1016/S1499-3872(11)60061-1
38. Escorsell A, Mas A, Fernandez J, Garcia-Valdecasas JC: Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation. Transplant Proc 2012,44(6):1539-1541. 10.1016/j.transproceed.2012.05.023
39. Krenn CG, Schafer B, Berlakovich GA, Steininger R, Steltzer H, Spiss CK: Detection of graft nonfunction after liver transplantation by assessment of indocyanine green kinetics. Anesth Analg 1998,87(1):34-36.
40. Yamanaka N, Okamoto E, Kato T, Fujihara S, Sasase S, Oriyama T, Fujimoto J, Furukawa K, Kawamura E, Tomoda F: Usefulness of monitoring the ICG retention rate as an early indicator of allograft function in liver transplantation. Transplant Proc 1992,24(4):1614-1617.
41. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001,345(19):1368-1377. 10.1056/NEJMoa010307